Yannick Viossat
Overview
Explore the profile of Yannick Viossat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
203
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ernesto Alvarez F, Viossat Y
J Math Biol
. 2024 Mar;
88(4):41.
PMID: 38446165
Clinical and pre-clinical data suggest that treating some tumors at a mild, patient-specific dose might delay resistance to treatment and increase survival time. A recent mathematical model with sensitive and...
2.
Patil S, Ahmed A, Viossat Y, Noble R
bioRxiv
. 2023 Dec;
PMID: 38045391
First-line cancer treatment frequently fails due to initially rare therapeutic resistance. An important clinical question is then how to schedule subsequent treatments to maximize the probability of tumour eradication. Here,...
3.
West J, Adler F, Gallaher J, Strobl M, Brady-Nicholls R, Brown J, et al.
Elife
. 2023 Mar;
12.
PMID: 36952376
Adaptive therapy is a dynamic cancer treatment protocol that updates (or 'adapts') treatment decisions in anticipation of evolving tumor dynamics. This broad term encompasses many possible dynamic treatment protocols of...
4.
Stein A, Salvioli M, Garjani H, Dubbeldam J, Viossat Y, Brown J, et al.
Philos Trans R Soc Lond B Biol Sci
. 2023 Mar;
378(1876):20210495.
PMID: 36934755
Stackelberg evolutionary game (SEG) theory combines classical and evolutionary game theory to frame interactions between a rational leader and evolving followers. In some of these interactions, the leader wants to...
5.
Noble R, Burri D, Le Sueur C, Lemant J, Viossat Y, Kather J, et al.
Nat Ecol Evol
. 2021 Dec;
6(2):207-217.
PMID: 34949822
Characterizing the mode-the way, manner or pattern-of evolution in tumours is important for clinical forecasting and optimizing cancer treatment. Sequencing studies have inferred various modes, including branching, punctuated and neutral...
6.
Viossat Y, Noble R
Nat Ecol Evol
. 2021 Apr;
5(6):826-835.
PMID: 33846605
Recent studies have shown that a strategy aiming for containment, not elimination, can control tumour burden more effectively in vitro, in mouse models and in the clinic. These outcomes are...
7.
Optimal control to reach eco-evolutionary stability in metastatic castrate-resistant prostate cancer
Cunningham J, Thuijsman F, Peeters R, Viossat Y, Brown J, Gatenby R, et al.
PLoS One
. 2020 Dec;
15(12):e0243386.
PMID: 33290430
In the absence of curative therapies, treatment of metastatic castrate-resistant prostate cancer (mCRPC) using currently available drugs can be improved by integrating evolutionary principles that govern proliferation of resistant subpopulations...
8.
Strobl M, West J, Viossat Y, Damaghi M, Robertson-Tessi M, Brown J, et al.
Cancer Res
. 2020 Nov;
81(4):1135-1147.
PMID: 33172930
Adaptive therapy seeks to exploit intratumoral competition to avoid, or at least delay, the emergence of therapy resistance in cancer. Motivated by promising results in prostate cancer, there is growing...
9.
Michod R, Viossat Y, Solari C, Hurand M, Nedelcu A
J Theor Biol
. 2005 Nov;
239(2):257-72.
PMID: 16288782
The fitness of an evolutionary individual can be understood in terms of its two basic components: survival and reproduction. As embodied in current theory, trade-offs between these fitness components drive...